Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haddad

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
Pharmacogenetics and Genomics|July 11, 2020
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancerJames N Ingle, Krishna R Kalari, Poulami Barman, et al.
BMJ Open|June 1, 2026
WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibility trialPravesh Sharma, Kaylynn G Imsande, Anni Vitriago, et al.
Cancer|October 30, 2015
Clinicopathologic features of breast cancers that develop in women with previous benign breast diseaseDaniel W Visscher, Marlene H Frost, Lynn C Hartmann, et al.
Oncogene|March 6, 2021
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistanceMohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast CancerBrian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Clinical Breast Cancer|November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic ExperienceNusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2024
Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective TrialTufia C Haddad, Vera J Suman, Karthik V Giridhar, et al.
Contemporary Clinical Trials Communications|May 29, 2026
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiationUgur Sener, Bryan Neth, Taylor Galloway, et al.
Telemedicine Reports|June 20, 2022
A Scalable Framework for Telehealth: The Mayo Clinic Center for Connected Care Response to the COVID-19 PandemicTufia C Haddad, Rebecca N Blegen, Julie E Prigge, et al.
NEJM Catalyst Innovations in Care Delivery|July 8, 2026
Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Safety, Feasibility, and Patient Experience of Home-Based ChemotherapyRoxana S Dronca, Jeremy C Jones, Michael J Maniaci, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
Pharmacogenetics and Genomics|July 11, 2020
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancerJames N Ingle, Krishna R Kalari, Poulami Barman, et al.
BMJ Open|June 1, 2026
WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibility trialPravesh Sharma, Kaylynn G Imsande, Anni Vitriago, et al.
Cancer|October 30, 2015
Clinicopathologic features of breast cancers that develop in women with previous benign breast diseaseDaniel W Visscher, Marlene H Frost, Lynn C Hartmann, et al.
Oncogene|March 6, 2021
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistanceMohammad Jalalirad, Tufia C Haddad, Jeffrey L Salisbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast CancerBrian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Clinical Breast Cancer|November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic ExperienceNusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2024
Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective TrialTufia C Haddad, Vera J Suman, Karthik V Giridhar, et al.
Contemporary Clinical Trials Communications|May 29, 2026
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiationUgur Sener, Bryan Neth, Taylor Galloway, et al.
Telemedicine Reports|June 20, 2022
A Scalable Framework for Telehealth: The Mayo Clinic Center for Connected Care Response to the COVID-19 PandemicTufia C Haddad, Rebecca N Blegen, Julie E Prigge, et al.
NEJM Catalyst Innovations in Care Delivery|July 8, 2026
Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Safety, Feasibility, and Patient Experience of Home-Based ChemotherapyRoxana S Dronca, Jeremy C Jones, Michael J Maniaci, et al.
Pageof 23